By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
News for IndiaNews for IndiaNews for India
  • Home
  • Posts
  • Search Page
  • About us
Reading: Stocks to buy or sell: Dharmesh Shah of ICICI Securities suggests buying Sun Pharma shares on 5 May 2025 | Stock Market News
Share
Font ResizerAa
News for IndiaNews for India
Font ResizerAa
  • Economics
  • Business
  • Home
  • Categories
    • Business
    • Economics
  • About us
  • Sitemap
Follow US
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
News for India > Business > Stocks to buy or sell: Dharmesh Shah of ICICI Securities suggests buying Sun Pharma shares on 5 May 2025 | Stock Market News
Business

Stocks to buy or sell: Dharmesh Shah of ICICI Securities suggests buying Sun Pharma shares on 5 May 2025 | Stock Market News

Last updated: May 4, 2025 10:14 am
3 months ago
Share
SHARE


Contents
Market Outlook by Dharmesh Shah, Vice President, ICICI SecuritiesStocks To Buy This Week – Dharmesh Shah

Stock market news: The domestic equity market benchmark indices, Sensex and Nifty 50, saw a minor uptick on Friday, ending off day’s high, as investors resorted to profit-booking at higher levels. Optimism surrounding a potential India-US trade deal, record high April GST collection, and continuous inflow of foreign funds, was offset by potential geopolitical tensions brewing between India and Pakistan.

The 30-share BSE Sensex trimmed most of the intraday gains to settle 259.75 points, or 0.32%, higher at 80,501.99. During the day, the benchmark jumped 935.69 points or 1.16% to 81,177.93. The NSE Nifty 50 closed 12.50 points, or 0.05%, higher at 24,346.70 amid high volatility.

Positive global market cues also supported the Indian stock market, however, cautiousness on the domestic front weighed on the sentiment.

Also Read | Sensex, Nifty 50 erase most gains—here are 10 key highlights

Dharmesh Shah, Vice President at ICICI Securities, expects a possibility of knee-jerk reaction on escalation of geopolitical worries, but advises investors not to panic but rather build quality portfolios from medium to long term perspective amid ongoing Q4 results season.

Shah has recommended one stock to buy for short-term. Here’s what he expects from Indian stock market next week, along with his stock recommendation.

Market Outlook by Dharmesh Shah, Vice President, ICICI Securities

1. Equity benchmark witnessed a lacklustre week amid stock specific action and settled the truncated week with marginal gains. In line with our expectation, the Nifty 50 index witnessed stiff resistance around 24,500 on multiple occasion in current week, indicating profit booking at higher levels. However, the index relatively outperformed the Broader market as it gained 1.2%. Meanwhile, beaten down Infra & Realty index witnessed pickup activity where it gained, 2.3% and 2.6% respectively for the week.

2. The weekly price action resulted in a small bull candle with long upper shadow, indicating prolonged consolidation after recent sharp up move. However, formation of higher high- low signifies that broader uptrend remains intact. Additionally, the ratio chart of Nifty 50/Nifty Midcap witnessed falling trendline breakout suggesting the benchmark to continue its outperformance.

3. In the upcoming week, we expect volatility to remain elevated tracking geopolitical worries wherein Nifty 50 is likely to consolidate in the broader range of 24,500-23,500 zone and witness stock specific amid earning season. On the oscillator front, the weekly stochastic oscillator is in overbought territory (placed at 92), indicating the ongoing breather to continue. However, we expect the market to trade with a positive bias where the current breather would help index to form higher base and close above 24,500 which will further fuel the rally towards the psychological mark of 25,000.

Also Read | Stocks to buy under ₹200: Mehul Kothari recommends three shares to buy or sell

4. For the coming week, strong support is placed at 23,800-23,500 zone. Meanwhile, on the upside, 24,500 would continue to act as immediate resistance.

5. In current scenario, possibility of knee-jerk reaction on escalation of geopolitical worries cannot be ruled out. However, historical evidences suggest that market will eventually stabilise. Hence, we advise not to panic but rather build quality portfolios from medium to long term perspective amid ongoing earning season.

6. There has been an ancient market saying of “sell in May and go away”. However, the historical data suggests that the Nifty 50 has witnessed positive returns in 9 out of 12 years (2013-2024) with an average return of 2.1%. This makes us believe that any dip amid volatility related to domestic and global factors should be capitalized a buying opportunity.

7. The blend of following parameters makes us believe that the index has formed a durable bottom. Tracking the historical data, benchmark index has staged a strong rebound after approaching the price and time wise correction. Key point to highlight is that, the current up move is backed by the faster pace of retracement, indicating structural turnaround that has been further validated by significant improvement in momentum, breadth as well as sentiment indicators.

8. Amidst ongoing volatility, following are the key monitorable which would act as tailwind:

a) Bilateral Trade Agreement between India and US

b) Continuation of FII’s inflow

c) Further strengthening of Rupee post 1.5% of correction in last week augurs well for equity market.

d) Decline in Brent crude oil prices

Stocks To Buy This Week – Dharmesh Shah

Dharmesh Shah of ICICI Securities recommends buying Sun Pharmaceutical Industries shares.

Buy Sun Pharmaceutical Industries shares in the price range of ₹1,780 – 1,833. He has Sun Pharma share price target of ₹2,040, and suggests maintaining a stop loss of ₹1,687.

Also Read | Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — 5 April

Disclaimer: The Research Analyst or his relatives or I-Sec do not have actual/beneficial ownership of 1% or more securities of the subject company, at the end of 02/05/2025 or have no other financial interest and do not have any material conflict of interest.

The views and recommendations provided in this analysis are those of individual analysts or broking companies, not Mint. We strongly advise investors to consult with certified experts before making any investment decisions, as market conditions can change rapidly and individual circumstances may vary.



Source link

You Might Also Like

Bajaj Auto Q1 Results: Net profit rises 5.4% to ₹2,096 crore; margins slip to multi-quarter low | Stock Market News

INR vs USD: Indian rupee falls to record low! Opportunity to buy IT stocks for short-term? | Stock Market News

Bajaj Auto Q1 Results LIVE Updates: Net profit, revenue likely to see modest growth, margins may fall | Stock Market News

Federal Bank underperforms Nifty Bank sharply, but the best may be yet to come

RBI Policy Outcome: How should investors position themselves as central bank keeps repo rate unchanged? | Stock Market News

TAGGED:5 May 2025Buy or sellDharmesh ShahDharmesh shah stock picksDharmesh Shah Stock recommendationsICICI SecuritiesMarket OutlookNifty 50sensexStock market newsstock market outlookStock picksstock recommendationsstocks to buystocks to buy this weeksun pharma share priceSun Pharma share price targetSun Pharma shares
Share This Article
Facebook Twitter Email Print
Previous Article SBI share price: Should you buy this stock after Q4 results 2025? | Stock Market News
Next Article Q4 results 2025: L&T, Paytm, Swiggy, M&M, BSE among companies to declare earnings next week; check full list here | Stock Market News

We influence 20 million users and is the number one business and technology news network on the planet.

Find Us on Socials

News for IndiaNews for India
© Wealth Wave Designed by Preet Patel. All Rights Reserved.
  • BUSINESS